MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.fertnstert.2011.09.020

Медицинская библиотека · Fertility and sterility · 2011

Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial.

Palomba Stefano, Falbo Angela, Carrillo Laura, Villani Maria Teresa, Orio Francesco, Russo Tiziana, Di Cello Annalisa, Cappiello Fulvio, Capasso Sabina, Tolino Achille, Colao Annamaria, Mastrantonio Pasquale, La Sala Giovanni Battista, Zullo Fulvio, Cittadini Ettore, METformin in High Responder Italian Group

СтатьяМногоцентровое исследованиеРандомизированное исследованиеПеревод в очереди

Аннотация

OBJECTIVE

To test whether metformin administration reduces the incidence of ovarian hyperstimulation syndrome (OHSS) in infertile high-risk patients with polycystic ovary syndrome (PCOS) who have been treated with gonadotropins for IVF.

DESIGN

Parallel, randomized, double-blind, placebo-controlled clinical trial.

SETTING

Academic departments, general hospital, and IVF centers.

PATIENT(S): One hundred twenty patients with PCOS at high risk for OHSS.

INTERVENTION(S): Gonadotropins ovarian stimulation for IVF and metformin (500 mg three times daily) or placebo tablets (three times daily).

MAIN OUTCOME MEASURE(S): The primary end point of the current clinical trial was the rate of OHSS. Anthropometric and reproductive data were evaluated.

RESULT(S): The total OHSS and cancellation rates were significantly reduced in patients treated with metformin. The relative risk for OHSS was of 0.28 (95% confidence interval, 0.11-0.67). With metformin the stimulation length and the total amount of gonadotropins used were significantly increased, whereas the peak E(2) levels were significantly reduced.

CONCLUSION(S): In patients with PCOS who are at high risk for OHSS and who have been stimulated with gonadotropins for IVF cycles, metformin reduces the risk of OHSS by modulating the ovarian response to the stimulation. REGISTRATION ID NUMBER FROM CLINICALTRIALS.GOV: NCT01233206.

Для цитирования: Palomba Stefano, Falbo Angela, Carrillo Laura, Villani Maria Teresa, Orio Francesco, Russo Tiziana, Di Cello Annalisa, Cappiello Fulvio, Capasso Sabina, Tolino Achille, Colao Annamaria, Mastrantonio Pasquale, La Sala Giovanni Battista, Zullo Fulvio, Cittadini Ettore, METformin in High Responder Italian Group. Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial.. Fertility and sterility. 2011. DOI: 10.1016/j.fertnstert.2011.09.020.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.